NCT00219076View on ClinicalTrials.gov

A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Amlodipine in Hypertensive Non Responders Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

504

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

October 31, 2005

Conditions

Hypertension

Interventions

DRUG

aliskiren

Trial Locations (2)

Unknown

Novartis Pharmaceuticals, East Hanover

Investigative Centers

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY